Efficacy and Safety of Pneumostem® for IVH in Premature Infants (Phase 2a)
Status:
Recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
The objective of this study is to evaluate the efficacy and safety of a single
intraventricular administration of Pneumostem® for treatment of Intraventricular hemorrhage
(IVH) in high-risk premature infants by comparing Pneumostem-treated group with a control
group.